MEET THE TEAM
Professor Sidney Altman
NOBEL PRIZE WINNER
Nobel Prize winner in chemistry (1989) for his discoveries concerning the catalytic properties of RNA. Sterling Professor of Molecular, Developmental, and Cellular Biology and Chemistry at Yale University, specializes in molecular biology, he worked in renowned universities such as Harvard, Yale and Cambridge.
Professor Arieh Warshel
NOBEL PRIZE WINNER
Nobel Prize winner in chemistry (2013) for the development of multiscale models for complex chemical systems. Professor Warshel is a pioneer in computational studies on functional properties of biological molecules. Distinguished Professor of Chemistry and Biochemistry at University of Southern California in Los Angeles, USA, also worked in other renowned research institutes, such as Weizmann Institute of Science, Israel and the Laboratory of Molecular Biology at Cambridge, England.
Professor Stefan Bornstein
Director of the Centre for Internal Medicine and the Medical Clinic and Policlinic III at the University Hospital Carl Gustav Carus of the Technical University of Dresden as well as the medical faculty’s vice dean of international affairs and development and a member of the supervisory board of the University Hospital of Dresden. He is also the chair and honorary consultant for diabetes and endocrinology at King’s College London.
Professor Gil Lebiowitz
Senior Physician in the Endocrinology and Metabolism Service, Hadassah Medical Centre, Chairman of the Diabetes mellitus study centre in the Hebrew University.
Professor Eduardo Mitrani
INVENTOR OF BETALIN'S TECHNOLOGY
Professor of Developmental Biology at the Institute of Life Sciences at the Hebrew University of Jerusalem. Specializes in tissue engineering and adult tissue repair and regeneration.
BOARD OF DIRECTORS
Mr Joshua Hershcovich
CHAIRMAN AND FOUNDER
Mr. Hershcovich is the Chairman of the Board. He has vast hands-on experience in capital markets, mergers and acquisitions, and developing public companies from a financial and entrepreneurial perspective
Mr Shay Hershcovich
Mr. Hershcovich is an investment strategist with BA and MBA in Business Management, manages the company’s investment strategy and supports its Business Development activities
Mr Zohar Pinhasi
A former IT security intelligence officer for the Israeli military, he is the founder and CEO of MonsterCloud, a leader in ransomware removal and managed cyber security services backed by former FBI Deputy Director John Pistole. Mr. Pinhasi is an avid anti-ransomware advocate, providing cyber threat intelligence to some of the world’s top authorities, including The Federal Bureau of Investigation (FBI) and dozens of police departments and municipalities across the United States.
Mr Cao Kun
Director of International Cooperation & Investment, Zhongguancun Medical Engineering & Translation Center (MTP). Mr. Kun specialized in the investment, financing, innovation management and business development of the advanced technology/product and SMEs in the field of healthcare/life science.
Mr Asaf Bartfled
Asaf Bartfeld has served as the Chief Executive and President of Delek Group, one of the largest Energy Companies in Israel since 2013. Bartfeld retired from Delk Group at the end of 2019 after serving in various functions at the company for more than 30 years including the CFO of Delek Geoup. Bartfeld has held several senior positions at Delek Group during his time at the company, including Chairman or director in several Delek Group subsidiaries and affiliates including companies in the USA and England.
Dr Nikolai Kunicher
C E O
Dr. Kunicher has experience in Biotech R&D management and extensive knowledge of the IP management for companies such as, ARTSaVIT and AVA Biodefender. Served as Scientific Manager and Head of Business Development at Surgical Innovation and Technology Center, Hadassah Medical Center.
Dr Avi Treves
Dr. Treves has wide experience in translational research and clinical development in the fields of regenerative medicine and cell technologies and immuno-oncology as well as business development of biotech companies, commercialization of hospitals and academic institutes programs. Dr. Treves is co-author of more than 100 scientific publications and 10 patents. Dr. Treves was the founder and CEO of Hadasit Ltd. and Gamida-Cell Ltd (Nasdaq GMDA).
Dr Orit Goldman
HEAD OF R&D LABORATORY
Dr. Goldman has experience in both basic and clinical research, having worked in several top research institutes in France, USA and Israel. Dr. Goldman is an expert in basic and clinical stem cell research, embryology, molecular and cell biology, biochemistry, and translational and oncological research.
Dr Karina Durlacher-Betzer
Dr. Durlacher- Betzer has extensive experience in cell culture, molecular biology and rodent research, in preclinical R&D. She also has experience in establishing and managing new experimental systems including immuno based in vitro and in vivo projects.
Ms Yaara Nester
PROJECT COORDINATOR & MEDICAL WRITER
Ms. Netser completed her undergraduate studies with honors in Biotechnology at Hadassah Academic College and her Masters in Cell and Developmental Biology at the Hebrew University of Jerusalem. She has extensive knowledge about drug development pathways including clinical studies and highly experienced in writing and submitting scientific files and applications.
Dr Bianca Patel
SCIENTIFIC PROJECT MANAGER (BETALINUK)
Dr. Patel completed her PhD in neuroendocrinology from the University of Leeds. She has a vast amount of in vivo and in vitro skills, with extensive knowledge in diabetes research. Dr. Patel has established Betalin Therapeutics first lab in the UK.
Dr Vered Ben-Hur
TEAM LEADER & PROJECT MANAGER
Dr. Ben-Hur holds a Ph.D. in Biochemistry and Molecular Biology from the Hebrew University, Faculty of Medicine. Dr. Ben-Hur has over 10 years of research experience, mainly in the fields of cancer cell biology, molecular biology, Immuno-oncology and stem cell differentiation. She brings expertise in pre-clinical trials, cGMP regulations and development of drug and cell-based products with an emphasis on transition to manufacturing.
Ms Menucha Nadav
Ms. Nadav completed her undergraduate studies with honours in Biotechnology at Hadassah Academic College and her Masters in Cell and Developmental Biology at the Hebrew University of Jerusalem. She has extensive experience in various in vitro and in vivo methods. At Betalin, she has become proficient at stem cells and in vivo transplantation methods.
Ms Chaya Spiegel
Ms. Spiegel has a BSc. In Biotechnology from Hadassah Academic college and a MSc. In Cell Biology from Hebrew University. She specializes in cell culture and molecular biology.
Mr Noam Mizrahi
LAB TECHNICIAN & QC
Mr. Noam Mizrahi is a dedicated engineer combining experience in GMP pharmaceutical manufacturing (e.g., biochemical processes, lyophilization) , quality control of raw and packaging materials according to regulations/ pharmacopeia, and utilities system qualification and monitoring
Mr Dima Puchinsky
LAB TECHNICIAN & QC
Mr. Puchinsky is an experienced technologist with BSc in biotechnology and MSc in biotechnology management. Experienced in sterile room working according to GMP conditions and the strict FDA rules at Teva.